New Century Healthcare Reports 26.8% Revenue Decline, RMB41.1 Million Loss for H1 2025

Reuters
2025/08/27
<a href="https://laohu8.com/S/NCRE">New Century</a> Healthcare Reports 26.8% Revenue Decline, RMB41.1 Million Loss for H1 2025

New Century Healthcare Holding Co. Ltd. reported its interim results for the six months ended June 30, 2025. The company recorded a revenue of RMB304.5 million, reflecting a 26.8% year-on-year decrease compared to the same period last year. Revenue from medical services was RMB301.0 million, a 27.0% decline, with pediatric services experiencing a 29.2% drop to RMB255.7 million, comprising 85.0% of the total medical services revenue. The number of pediatric outpatient visits decreased by 25.6% to 88,045. The company reported a loss before income tax of RMB41.1 million, contrasting a profit before income tax of RMB72.2 million in the same period of 2024. This loss was primarily due to a revenue decrease of RMB111.5 million and impairment losses of RMB33.7 million on certain goodwill and property, plant, and equipment. Revenue from outpatient medical services decreased by 25.4% to RMB182.5 million, while inpatient revenue declined by 29.3% to RMB102.8 million. No dividend was declared or paid to Beijing Children's Hospital, Capital Medical University, a non-controlling shareholder of Beijing New Century Children's Hospital Co., Ltd., a subsidiary of the Group.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. New Century Healthcare Holding Co. Ltd. published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10